@article{article8077b9da,
title   = {Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease},
author = {Nitrini, Ricardo and Studart Neto, Adalberto},
year = {2025},
doi = {10.1055/s-0045-1808082},
journal   = {Arquivos de Neuro-Psiquiatria}
}